LUMOXITI
These highlights do not include all the information needed to use LUMOXITI safely and effectively. See full prescribing information for LUMOXITI. LUMOXITI (moxetumomab pasudotox-tdfk) for injection, for intravenous use Initial U.S. Approval: 2018
8ddffb08-aab1-41f5-bbc6-09457e4e80ca
HUMAN PRESCRIPTION DRUG LABEL
Sep 3, 2020
Innate Pharma, Inc.
DUNS: 117202909
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
POLYSORBATE 80
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
MOXETUMOMAB PASUDOTOX
Product Details
FDA regulatory identification and product classification information